[Value of gastric acidification by vagoserine in the treatment of gastroesophageal reflux].
D000328:Adult; D000368:Aged; D004338:Drug Combinations / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D005750:Gastric Juice / Q000187:drug effects*; D005764:Gastroesophageal Reflux / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D005971:Glutamates / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010206:Papain / Q000494:pharmacology / Q000627:therapeutic use*; D010830:Physostigmine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
D004338:Drug Combinations; D005971:Glutamates; C024165:vagoserine; D010830:Physostigmine; D010206:Papain
Intérêt de l'acidification gastrique par la Vagosérine dans le traitement du reflux gastro-oesophagien.